Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H15ClO2 |
Molecular Weight | 214.689 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)C(C)(O)C1=CC=C(Cl)C=C1
InChI
InChIKey=HTYIXCKSEQQCJO-UHFFFAOYSA-N
InChI=1S/C11H15ClO2/c1-10(2,13)11(3,14)8-4-6-9(12)7-5-8/h4-7,13-14H,1-3H3
CNS Activity
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/806427 |
Primary | Ultran |
Doses
Dose | Population | Adverse events |
---|---|---|
1000 mg 3 times / day multiple, oral Studied dose Dose: 1000 mg, 3 times / day Route: oral Route: multiple Dose: 1000 mg, 3 times / day Sources: Page: p.284 |
unhealthy, 1 - 18 n = 44 Health Status: unhealthy Condition: Cerebral palsy Age Group: 1 - 18 Sex: M+F Population Size: 44 Sources: Page: p.284 |
|
300 mg 4 times / day multiple, oral Studied dose Dose: 300 mg, 4 times / day Route: oral Route: multiple Dose: 300 mg, 4 times / day Sources: Page: p.280 |
unhealthy, 21 - 65 n = 70 Health Status: unhealthy Condition: Anxiety|depression Age Group: 21 - 65 Sex: M+F Population Size: 70 Sources: Page: p.280 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
||
|
NCI_THESAURUS |
C28197
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6617
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105293
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
LMQ31KU50K
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
169451
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
63894
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
638
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
79-93-6
Created by
admin on Fri Dec 15 15:04:08 GMT 2023 , Edited by admin on Fri Dec 15 15:04:08 GMT 2023
|
PRIMARY | |||
|
100000082208
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
2116
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
DTXSID6023444
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
Phenaglycodol
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
201-235-3
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
C90611
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
C027886
Created by
admin on Fri Dec 15 15:04:09 GMT 2023 , Edited by admin on Fri Dec 15 15:04:09 GMT 2023
|
PRIMARY | |||
|
SUB09748MIG
Created by
admin on Fri Dec 15 15:04:08 GMT 2023 , Edited by admin on Fri Dec 15 15:04:08 GMT 2023
|
PRIMARY |
ACTIVE MOIETY